Diff	CONTEXT
erences	CONTEXT
Ġin	CONTEXT
Ġsurvival	CONTEXT
Ġand	CONTEXT
Ġimpact	CONTEXT
Ġof	CONTEXT
Ġadj	CONTEXT
u	CONTEXT
vant	CONTEXT
Ġchemotherapy	CONTEXT
Ġin	CONTEXT
Ġpatients	CONTEXT
Ġwith	CONTEXT
Ġvariant	CONTEXT
Ġhist	CONTEXT
ology	CONTEXT
Ġof	CONTEXT
Ġtumors	CONTEXT
Ġof	CONTEXT
Ġthe	CONTEXT
Ġrenal	CONTEXT
Ġpel	CONTEXT
vis	CONTEXT
.	CONTEXT
ĠThe	CONTEXT
Ġimpact	CONTEXT
Ġof	CONTEXT
Ġvariant	CONTEXT
Ġhist	CONTEXT
ologies	CONTEXT
Ġon	CONTEXT
Ġoverall	CONTEXT
Ġsurvival	CONTEXT
Ġ(	CONTEXT
OS	CONTEXT
),	CONTEXT
Ġas	CONTEXT
Ġwell	CONTEXT
Ġas	CONTEXT
Ġtheir	CONTEXT
Ġinfluence	CONTEXT
Ġon	CONTEXT
Ġthe	CONTEXT
Ġresponse	CONTEXT
Ġto	CONTEXT
Ġne	CONTEXT
oad	CONTEXT
ju	CONTEXT
vant	CONTEXT
Ġand	CONTEXT
Ġadj	CONTEXT
u	CONTEXT
vant	CONTEXT
Ġchemotherapy	CONTEXT
Ġ(	CONTEXT
AC	CONTEXT
)	CONTEXT
Ġis	CONTEXT
Ġwell	CONTEXT
Ġstudied	CONTEXT
Ġin	CONTEXT
Ġpatients	CONTEXT
Ġdiagnosed	CONTEXT
Ġwith	CONTEXT
Ġbladder	CONTEXT
Ġcancer	CONTEXT
.	CONTEXT_END
Compared	O
Ġto	O
ĠP	B-BASELINE
UC	I-BASELINE
,	O
Ġad	B-EXPL_VAR
en	I-EXPL_VAR
oc	I-EXPL_VAR
arc	I-EXPL_VAR
in	I-EXPL_VAR
omas	I-EXPL_VAR
Ġshowed	O
Ġlonger	O
ĠOS	B-OUTCOME_VAR
Ġ(	O
HR	O
Ġ0	B-HR
.	I-HR
76	I-HR
,	O
Ġ95	O
%	O
Ġconfidence	O
Ġinterval	O
Ġ(	O
CI	O
)	O
Ġ0	O
.	O
62	O
-	O
0	O
.	O
94	O
,	O
Ġp	O
Ġ=	O
Ġ0	O
.	O
01	O
),	O
Ġwhile	O
Ġsar	B-EXPL_VAR
com	I-EXPL_VAR
at	I-EXPL_VAR
oid	I-EXPL_VAR
Ġtumors	I-EXPL_VAR
Ġhad	O
Ġshorter	O
ĠOS	B-OUTCOME_VAR
Ġ(	O
HR	O
Ġ1	B-HR
.	I-HR
59	I-HR
,	O
Ġ95	O
%	O
ĠCI	O
Ġ1	O
.	O
12	O
-	O
2	O
.	O
26	O
,	O
Ġp	O
Ġ=	O
Ġ0	O
.	O
011	O
).	O
